Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC (BMC Medical Research Methodology, (2023), 23, 1, (1), 10.1186/s12874-022-01760-0)

DSpace/Manakin Repository

Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC (BMC Medical Research Methodology, (2023), 23, 1, (1), 10.1186/s12874-022-01760-0)
 
Ismail, R K; Schramel, F M N H; van Dartel, M; Pasmooij, A M G; der Welle, C M Cramer-van; Hilarius, D L; de Boer, A; Wouters, M W J M; van de Garde, E M W
(2023) BMC Medical Research Methodology, volume 23, issue 1
(Comment)
Abstract
Following publication of the original article [1], the authors requested to correct the word “first-line” to “second-line” in the article title. The original article has been updated.
Download/Full Text
Open Access version via Utrecht University Repository Publisher version
 
DOI: https://doi.org/10.1186/s12874-023-01850-7
ISSN: 1471-2288
Publisher: BioMed Central
(Peer reviewed)
 
 
See more statistics about this item